Effect of mass campaigns with full and fractional doses of pneumococcal conjugate vaccine (Pneumosil) on the reduction of nasopharyngeal pneumococcal carriage in Niger: a three-arm, open-label, cluster-randomised trial.Coldiron ME
Soumana I
Baudin E
Langendorf C
Mamiafo Tchoula C
Brah S
Karani A
Gallagher KE
Kagucia EW
Scott JAG
Grais RF
Lancet Infect Dis, (2025). 25:634-642
"Though there are some challenges, we try our best to follow the guidelines": a qualitative study exploring determinants of providing guideline-adherent care to hospitalized children in Kenya.Coe MM
Shawon RA
Masheti M
Oduol C
Amam P
Olieng'o GO
Timbwa M
Kamui M
Thitiri J
Gimbel S
Singa B
Means AR
Implement Sci Commun, (2025). 6:110
Prevalence of epilepsy: a population-based cohort study in Denmark with comparison to Global Burden of Disease (GBD) prevalence estimates.Christensen J
Trabjerg BB
Wagner RG
Newton CR
Kwon CS
Aaberg KM
Trinka E
Wiebe S
Cross JH
Vegrim HM
Vos T
Steinmetz J
Dreier JW
J Neurol Neurosurg Psychiatry, (2025). 96:480-488
Spatio-temporal variations and determinants of antenatal care utilization among adolescents in Bulawayo metropolitan area, Zimbabwe: an analysis of routine data, 2019-2024.Chivanganye T
Siamuchembu M
Gumbo A
Benova L
Macharia PM
Geospat Health, (2025). 20:
Prevalence, incidence, and outcome of tuberculosis among young hospitalised children with acute illness in Sub-Saharan Africa and South East Asia.Chisti MJ
Mupere E
Shahid Asmsb
Mukisa J
Mamun GMS
Lwanga C
Shaima SN
Atuhairwe M
Kabir MF
Aber P
Ssengooba W
Shahrin L
Banu S
Graham SM
Walson JL
Berkley JA
Ahmed T
Lancioni CL
J Glob Health, (2025). 15:04338
Cardiac output measurement in Malawian children ages 2 months-12 years hospitalised with severe anaemia (COM-TRACT).Chintolo E
Connon R
George EC
Chagaluka G
M'Baya B
Walker AS
Kennedy N
Maitland K
Int Health, (2025). :
Pilot implementation of short message service for randomisation in a multisite pragmatic factorial clinical trial in Kenya.Chepkirui M
Kimego D
Nzioki C
Jowi E
Opondo C
Agweyu A
Pilot Feasibility Stud, (2025). 11:29
Corrigendum to 'Volatile pyrethroid spatial repellents for preventing mosquito bites: a systematic review and meta-analysis' EBioMedicine Volatile pyrethroid spatial repellents for preventing mosquito bites: a systematic review and meta-analysis 119 (2025) 105891/10.1016/j.ebiom.2025.105891 Sep: 119: 105891.Chen I
Miller SL
Msellemu D
Lugenge AG
Swai JK
Achee N
Andres M
Bibbs CS
Chareonviriyaphap T
Charlwood JD
Devine G
Elman N
Fillinger U
Flores-Mendoza C
Gibson S
Govella N
Gowelo S
Horstmann S
Kawada H
Kline D
Lloyd A
Lobo NF
Maia MF
Mmbando A
Moreno-Gomez M
Morrison AC
Mponzi W
Mwanga EP
Njoroge M
Ogoma SB
Okumu FO
Opiyo M
Oumbouke WA
Paliga J
Pongsiri A
Ponlawat A
Saeaung M
Salazar F
Sangoro O
Stevenson JC
Sukkanon C
Syafruddin D
Tambwe MM
Tangena JA
Vajda EA
Vazquez-Prokopec G
Wagman JM
Yan C
Allen IE
Moore SJ
EBioMedicine, (2025). 122:106049
Volatile pyrethroid spatial repellents for preventing mosquito bites: a systematic review and meta-analysis.Chen I
Miller SL
Msellemu D
Lugenge AG
Swai JK
Achee N
Andres M
Bibbs CS
Chareonviriyaphap T
Charlwood JD
Devine G
Elman N
Fillinger U
Flores-Mendoza C
Gibson S
Govella N
Gowelo S
Horstmann S
Kawada H
Kline D
Lloyd A
Lobo NF
Maia MF
Mmbando A
Moreno-Gomez M
Morrison AC
Mponzi W
Mwanga EP
Njoroge M
Ogoma SB
Okumu FO
Opiyo M
Oumbouke WA
Paliga J
Pongsiri A
Ponlawat A
Saeaung M
Salazar F
Sangoro O
Stevenson JC
Sukkanon C
Syafruddin D
Tambwe MM
Tangena JA
Vajda EA
Vazquez-Prokopec G
Wagman JM
Yan C
Allen IE
Moore SJ
EBioMedicine, (2025). 119:105891
Examining the impact of implementing routine rotavirus vaccination on the number of paediatric admissions due to diarrhoea and dehydration in Kenyan hospitals: A study using interrupted time series analysis.Chelangat D
Malla L
Langat RC
Akech S
Clinical Information Network Author Group
Wellcome Open Res, (2025). 7:2
Uptake and determinants of routine immunization among vulnerable children and adolescents in sub-Saharan Africa: A scoping review.Chege CK
Karanja S
Ogallo W
Were F
van Hensbroek MB
Agweyu A
Vaccine, (2025). 54:127021
Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa.Chanda C
Kibengo F
Mutua M
Ogada F
Muturi-Kioi V
Akis Yildirim BM
Amondi M
Baines A
Basajja V
Borthwick N
Bosire K
Chambula E
Chetty P
Chinyenze K
Chirro O
Crook A
De Bont J
Fernandez N
Ejou P
Farah B
Glaze M
Gombe B
Gumbe A
Hayes P
Itwi S
Juma S
Kabarambi A
Kabengele C
Kafeero P
Kakande A
Kanungi J
Kidega W
King D
Mahira R
Malogo R
Matsoso M
Michelo C
Moyo A
Mugaba S
Mugenya I
Muhumuza P
Mujadidi YF
Muriuki M
Musale V
Mutua G
Muwowo M
Mwale F
Mwangi I
Nakimbugwe M
Namuyanja A
Nduati E
Nielsen L
Nyange J
Oino G
Okech B
Omosa-Manyonyi G
Otieno D
Palmer S
Phiri H
Ramko K
Rutishauser RL
Sayeed E
Sajabi R
Serwanga J
GTWee E
Wenden C
Cicconi P
Fast P
Gilmour J
Jaoko W
Kaleebu P
Kilembe W
Kuipers H
Sanders EJ
Hanke T
Lancet Microbe, (2025). 6:101041
Trends in malaria prevalence among school-age children in Mainland Tanzania, 2015-2023: A multilevel survey analysis.Chacky F
Hicks JT
Remiji MJ
Rumisha SF
Walker PGT
Chaki P
Aaron S
Nhiga SL
Reaves E
Serbantez N
Molteni F
Ngasala B
Kc A
Mmbando BP
Snow RW
Van Geertruyden JP
PLOS Glob Public Health, (2025). 5:e0004386
Ivermectin to reduce malaria transmission- safety and efficacy results from the BOHEMIA cluster randomized trial in Mozambique.Chaccour C
Nicolas P
Martinho S
Mundaca H
Elobolobo E
Ruiz-Castillo P
Houana A
Montana J
Mbanze J
Casellas A
Macucha A
Mael M
Soares A
Kiuru C
Gutierrez AS
Imputiua S
Constantino L
Vegove V
Cole G
Duthaler U
Ribes M
Mutepa V
Brew J
Munguambe H
Stanulovic S
Xerinda A
Materula F
Gorski N
Wanjiku C
Furnival-Adams J
Tunez L
Sam L
Collins L
Xia K
Hammann F
Rudd M
Rist C
Jones C
Maia M
Candrinho B
Rabinovich NR
Saute F
EClinicalMedicine, (2025). 90:103632
Ivermectin to Control Malaria - A Cluster-Randomized Trial.Chaccour C
Maia M
Kariuki M
Ruiz-Castillo P
Wanjiku C
Kasiwa L
Brazeal A
Casellas A
Ngama M
Onyango T
Elobolobo E
Kazungu K
Mael M
Wangari W
Nuru K
Otuko R
Sanz A
Ringera I
Matano A
Mitora S
Ribes M
Brew J
Gorski N
Nicolas P
Stanulovic S
Omondi I
Furnival-Adams J
Tunez L
Mbarak J
Vegove V
Yaa E
Mramba S
Kibet Y
Nyambura N
Rotich C
Wanjiru S
Vura M
Wanjiku F
Sam L
Collins L
Xia K
Hammann F
Saute F
Rudd M
Rist C
Jones C
Mwangangi J
Rabinovich NR
N Engl J Med, (2025). 393:362-375
Re-thinking "non-response" to wasting treatment: Exploratory analysis from 14 studies.Cazes C
Stobaugh H
Bahwere P
Binns P
Black RE
Boyd E
Briend A
Isanaka S
Kangas ST
Khara T
Lelijveld N
Mwangome M
Myatt M
Odei Obeng-Amoako G
Trehan I
James PT
PLOS Glob Public Health, (2025). 5:e0003741
Sociodemographic influences on substance use in psychosis in an African cohort.Campbell ML
Odokonyero R
Akena D
Alemayehu M
Atwoli L
Chibnik LB
Gelaye B
Gichuru S
Kariuki SM
Koenen KC
Kwobah E
Kyebuzibwa J
Mwema RM
Newton CRJC
Post K
Pretorius A
Stevenson A
Stroud RE, 2nd
Teferra S
Zingela Z
Stein DJ
Hook K
Schizophr Res, (2025). 281:157-163
Validation of high-throughput oxford nanopore technology for HIV-1 transmitted/founder virus identification.Byamukama D
Ndekezi C
Omara D
Nakyanzi A
Natwijuka F
Kato F
Mugaba S
Kimuda MP
Kapaata A
Nduati E
Kaleebu P
Balinda SN
Int J Infect Dis, (2025). 161:108138
An adaptive multiarm randomised trial of biomedical and psychosocial interventions to improve convalescence following severe acute malnutrition in sub-Saharan Africa: Co-SAM trial protocol.Bwakura-Dangarembizi M
Amadi B
Singa BO
Muyemayema S
Ngosa D
Mwalekwa L
Ngao N
Kazhila L
Mutasa B
Mpofu E
Mudawarima L
Gonzales GB
Mudzingwa S
Mutenda M
Keter LK
Mutasa K
Njunge JM
Jones H
Phiri TN
Mudibo E
Chulu N
Majo FD
Chasekwa B
Tembo A
Nyabinda C
Oduol C
Sauramba V
Tavengwa NV
Langhaug L
Cordani I
Smuk M
Jaki T
Ntozini R
Walson J
Tickell KD
Berkley J
Kelly P
Prendergast AJ
Co SAMTrial Team
BMJ Open, (2025). 15:e093758
Vaccine-induced responses to R21/Matrix-M - an analysis of samples from a phase 1b age de-escalation, dose-escalation trial.Bundi C
Bellamy D
Kibwana E
Nyamako L
Ogwang R
Keter K
Kimani D
Salman AM
Provstgaard-Morys S
Stockdale L
Hill AVS
Bejon P
Olotu A
Hamaluba M
Ewer KJ
Kapulu MC
Front Immunol, (2025). 16:1620366
